NO940373L - Ikke-belagte tabletter og fremgangsmåte for fremstilling av disse - Google Patents
Ikke-belagte tabletter og fremgangsmåte for fremstilling av disseInfo
- Publication number
- NO940373L NO940373L NO940373A NO940373A NO940373L NO 940373 L NO940373 L NO 940373L NO 940373 A NO940373 A NO 940373A NO 940373 A NO940373 A NO 940373A NO 940373 L NO940373 L NO 940373L
- Authority
- NO
- Norway
- Prior art keywords
- oily
- fatty substance
- excipient
- compression
- active ingredient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
- F04C—ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT PUMPS
- F04C2210/00—Fluid
- F04C2210/26—Refrigerants with particular properties, e.g. HFC-134a
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Trykkstøptbar sammensetning omfattende en aktiv ingrediens, en eksipiens og et oljeaktig eller fettaktig stoff med et lavere smeltepunkt på omkring 20 til 90'C, blir trykkstøpt til ikke-belagte tabletter uten belegging for å forbedre slitasjemotstanden. Det oljeaktige eller fettaktige stoffet omfatter en høyere fettsyre eller et salt av denne, en voks, en fett- syreester, en herdet olje, et polyalkylenoksyd osv., og mengden av de.tte er omkring 0,01 til 10 vekt-*. Sammensetningen kan omfatte (1) et granulert pulver inneholdende den aktive Ingrediensen og eksipiensen, og det pulverformige eller granulære oljeaktige eller fettaktige stoffet med et lavere smeltepunkt, eller (2) et granulert pulver inneholdende den aktive ingredien- sen ,, eksipiensen og nevnte oljeaktige eller fettaktige stoff. Trykkstøping av sammensetningen forbedrer sli.tasjemotstanden til tabletten og hemmer signifikant utviklingen av pulver ved slitasje eller avriving selv når det oljeaktige eller fettaktige stoffet blir benyttet l en så liten mengde som omkring 0,1 til 0,5 vekt-*.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4595893 | 1993-02-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO940373D0 NO940373D0 (no) | 1994-02-04 |
NO940373L true NO940373L (no) | 1994-08-11 |
Family
ID=12733779
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO940373A NO940373L (no) | 1993-02-10 | 1994-02-04 | Ikke-belagte tabletter og fremgangsmåte for fremstilling av disse |
Country Status (10)
Country | Link |
---|---|
US (1) | US5456920A (no) |
EP (1) | EP0610854B1 (no) |
KR (1) | KR940019294A (no) |
CN (1) | CN1106652A (no) |
AT (1) | ATE191846T1 (no) |
CA (1) | CA2115308C (no) |
DE (1) | DE69423990T2 (no) |
FI (1) | FI940585A (no) |
NO (1) | NO940373L (no) |
TW (1) | TW272942B (no) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0553777B1 (en) * | 1992-01-29 | 2002-04-24 | Takeda Chemical Industries, Ltd. | Fast dissolving tablet and its production |
TW466119B (en) * | 1994-02-28 | 2001-12-01 | Janssen Pharmaceutica Nv | Film coated tablet of paracetamol and domperidone |
GB9421836D0 (en) * | 1994-10-28 | 1994-12-14 | Scherer Corp R P | Process for preparing solid pharmaceutical dosage forms of hydrophobic substances |
AU717764B2 (en) * | 1996-05-02 | 2000-03-30 | Taisho Pharmaceutical Co., Ltd. | Suspension of sparingly water-soluble acidic drug |
TW592727B (en) | 1997-04-04 | 2004-06-21 | Chugai Pharmaceutical Co Ltd | Phosphate-binding polymer preparations |
AU1234399A (en) * | 1997-11-25 | 1999-06-15 | Bayer Aktiengesellschaft | Sustained release formulations comprising alpha-glucosidase-i nhibitors |
WO1999050217A1 (en) * | 1998-03-31 | 1999-10-07 | Bayer Aktiengesellschaft | Valiolone, a method of preparing it, and its use to prepare acarbose and voglibose |
CH689452C1 (de) * | 1998-04-15 | 2004-11-30 | Marcel Christian Wegmueller | Verfahren zur Verhinderung von zementbedingten ablagerungen in einem Bauwerksentwaesserungssystem. |
US8124630B2 (en) | 1999-01-13 | 2012-02-28 | Bayer Healthcare Llc | ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
JP2002534468A (ja) | 1999-01-13 | 2002-10-15 | バイエル コーポレイション | p38キナーゼ阻害剤としてのω−カルボキシアリール置換ジフェニル尿素 |
ES2307482T3 (es) * | 1999-02-10 | 2008-12-01 | Pfizer Products Inc. | Dispersiones farmaceuticas solidas. |
US20020071864A1 (en) * | 1999-03-25 | 2002-06-13 | Yuhan Corporation | Rapidly disintegrable tablet for oral administration |
MXPA01012659A (es) * | 1999-06-07 | 2003-09-04 | Altana Pharma Ag | Nueva forma de administracion y preparacion que comprende un compuesto activo labil acido. |
CA2383212C (en) | 1999-09-02 | 2008-11-25 | Nostrum Pharmaceuticals, Inc. | Controlled release oral dosage suitable for oral administration |
US20100196466A1 (en) * | 2000-06-06 | 2010-08-05 | Capricorn Pharma Inc. | Drug delivery system |
US20070059367A1 (en) * | 2000-06-06 | 2007-03-15 | Cherukuri S R | Drug Delivery System and Associated Methods |
US20080058424A1 (en) * | 2002-05-23 | 2008-03-06 | Cephalon, Inc. | Novel pharmaceutical formulations of modafinil |
US7052706B2 (en) * | 2001-06-08 | 2006-05-30 | Nostrum Pharmaceuticals, Inc. | Control release formulation containing a hydrophobic material as the sustained release agent |
US6660292B2 (en) * | 2001-06-19 | 2003-12-09 | Hf Flavoring Technology Llp | Rapidly disintegrating flavored film for precooked foods |
US7122143B2 (en) | 2001-09-28 | 2006-10-17 | Mcneil-Ppc, Inc. | Methods for manufacturing dosage forms |
US6982094B2 (en) | 2001-09-28 | 2006-01-03 | Mcneil-Ppc, Inc. | Systems, methods and apparatuses for manufacturing dosage forms |
MXPA04002980A (es) | 2001-09-28 | 2005-06-20 | Johnson & Johnson | Formas de dosificacion que tienen un nucleo interior y coraza exterior con diferentes formas. |
US7838026B2 (en) | 2001-09-28 | 2010-11-23 | Mcneil-Ppc, Inc. | Burst-release polymer composition and dosage forms comprising the same |
US7323192B2 (en) * | 2001-09-28 | 2008-01-29 | Mcneil-Ppc, Inc. | Immediate release tablet |
US6837696B2 (en) * | 2001-09-28 | 2005-01-04 | Mcneil-Ppc, Inc. | Apparatus for manufacturing dosage forms |
WO2003068228A1 (en) | 2002-02-11 | 2003-08-21 | Bayer Pharmaceuticals Corporation | Aryl ureas with angiogenesis inhibiting activity |
US7011688B2 (en) * | 2002-05-10 | 2006-03-14 | C.R. Bard, Inc. | Prosthetic repair fabric |
US20040116532A1 (en) | 2002-09-13 | 2004-06-17 | Craig Heacock | Pharmaceutical formulations of modafinil |
US7807197B2 (en) * | 2002-09-28 | 2010-10-05 | Mcneil-Ppc, Inc. | Composite dosage forms having an inlaid portion |
US7557129B2 (en) | 2003-02-28 | 2009-07-07 | Bayer Healthcare Llc | Cyanopyridine derivatives useful in the treatment of cancer and other disorders |
US20070148229A1 (en) * | 2003-04-24 | 2007-06-28 | Jagotec Ag | Tablet with coloured core |
PT1636585E (pt) | 2003-05-20 | 2008-03-27 | Bayer Pharmaceuticals Corp | Diarilureias com actividade inibidora de cinase |
US8637553B2 (en) | 2003-07-23 | 2014-01-28 | Bayer Healthcare Llc | Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions |
FR2862187B1 (fr) * | 2003-11-19 | 2006-02-24 | Sbm Dev | Nouvelles compositions agrochimiques et leur procede de fabrication |
FR2867025B1 (fr) * | 2004-03-05 | 2006-06-02 | Sbm Dev | Compositions agrochimiques solides a desagregation rapide |
US8673352B2 (en) | 2005-04-15 | 2014-03-18 | Mcneil-Ppc, Inc. | Modified release dosage form |
DE102005028696A1 (de) * | 2005-06-21 | 2006-12-28 | Pulmotec Gmbh | Verwendung eines Hilfsstoffs zur Einstellung der Abrasionsfestigkeit eines verfestigten Wirkstoffpräparats |
MY149863A (en) | 2006-08-03 | 2013-10-31 | Nitec Pharma Ag | Delayed-release glucocorticoid treatment of rheumatoid disease |
TW200829286A (en) * | 2006-09-06 | 2008-07-16 | Genzyme Corp | Polystyrene sulfonate polymer tablets, their preparation and use |
JP5410290B2 (ja) * | 2006-10-27 | 2014-02-05 | エフ エム シー コーポレーション | 共処理組成物とその製造方法、打錠可能な錠剤処方物、錠剤の製造方法及び錠剤 |
US10610528B2 (en) | 2009-12-08 | 2020-04-07 | Intelgenx Corp. | Solid oral film dosage forms and methods for making same |
US20110136815A1 (en) | 2009-12-08 | 2011-06-09 | Horst Zerbe | Solid oral film dosage forms and methods for making same |
WO2019246384A1 (en) | 2018-06-21 | 2019-12-26 | Aquestive Therapeutics, Inc. | System and method for making personalized individual unit doses containing pharmaceutical actives |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0070127A3 (en) * | 1981-07-10 | 1983-08-17 | Beecham Group Plc | Tablets |
JPH01308231A (ja) * | 1988-06-03 | 1989-12-12 | Takeda Chem Ind Ltd | 安定化された医薬組成物および製造法 |
JPH0425926A (ja) * | 1990-05-22 | 1992-01-29 | Toshiba Corp | 情報処理装置 |
TW284688B (no) * | 1991-11-20 | 1996-09-01 | Takeda Pharm Industry Co Ltd |
-
1994
- 1994-01-19 TW TW083100405A patent/TW272942B/zh active
- 1994-01-28 US US08/187,908 patent/US5456920A/en not_active Expired - Lifetime
- 1994-02-04 NO NO940373A patent/NO940373L/no unknown
- 1994-02-07 EP EP94101809A patent/EP0610854B1/en not_active Expired - Lifetime
- 1994-02-07 AT AT94101809T patent/ATE191846T1/de not_active IP Right Cessation
- 1994-02-07 DE DE69423990T patent/DE69423990T2/de not_active Expired - Lifetime
- 1994-02-08 CN CN94101367A patent/CN1106652A/zh active Pending
- 1994-02-08 KR KR1019940002475A patent/KR940019294A/ko not_active Application Discontinuation
- 1994-02-09 FI FI940585A patent/FI940585A/fi unknown
- 1994-02-09 CA CA002115308A patent/CA2115308C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US5456920A (en) | 1995-10-10 |
CA2115308C (en) | 2004-05-11 |
EP0610854A1 (en) | 1994-08-17 |
CA2115308A1 (en) | 1994-08-11 |
FI940585A (fi) | 1994-08-11 |
NO940373D0 (no) | 1994-02-04 |
DE69423990T2 (de) | 2000-08-17 |
ATE191846T1 (de) | 2000-05-15 |
EP0610854B1 (en) | 2000-04-19 |
CN1106652A (zh) | 1995-08-16 |
KR940019294A (ko) | 1994-09-14 |
DE69423990D1 (de) | 2000-05-25 |
TW272942B (no) | 1996-03-21 |
FI940585A0 (fi) | 1994-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO940373L (no) | Ikke-belagte tabletter og fremgangsmåte for fremstilling av disse | |
AU587863B2 (en) | Vitamin-containing granules and production thereof | |
NO175240C (no) | Fremgangsmåte for fremstilling av et langsomt frigivende farmasöytisk preparat som omfatter sekundære granuler | |
JPS56140915A (en) | Pharmaceutical preparation for solid drug | |
HU9300700D0 (en) | Concentrated solid dosing forms with high active agent content such as pills, granular powders and pellets | |
DK0385582T3 (da) | Nifedipin-holdige farmaceutiske præparater og fremgangsmåde til fremstilling heraf | |
FI945452A0 (fi) | Ibuprofeenia sisältävä poreileva lääkevalmiste sekä sen valmistusmenetelmä | |
FR2514261B1 (fr) | Nouvelle composition pour l'enrobage des aliments et des medicaments et granules ainsi enrobes | |
IE891414L (en) | Pharmaceutical compositions | |
ES2076358T3 (es) | Granulados con elevado contenido de ibuprofeno. | |
BR9813149A (pt) | Complexo de carragenano, processo para preparação do mesmo, composição farmacêutica de liberação controlada, e, processos pra preparar composições farmecêuticas de liberação controlada na forma de tabletes e na forma de glânulos ou na forma de pelotas | |
ITMI931014A1 (it) | Composizione farmaceutica a lento rilascio contenente come sostanza attiva un acido biliare | |
IL110149A0 (en) | Hygroscopic plant growth regulator formulations and their preparation | |
CA2046308A1 (en) | Radiolabeled colloid compositions, their use and process for their preparation | |
AU5603890A (en) | Particulate solid of an isothiazolinone or isothiazolothione | |
FR2656772B1 (fr) | Procede d'incorporation dans des pellets de principes actifs proteges contre la degradation dans la panse des ruminants. | |
ZA871145B (en) | Compositions for the release of biologically active substances into desired environments | |
BR0006230B1 (pt) | Composição na forma de um pó ou grânulos compreendendo ácido ascórbico e pectina, e processo para sua preparação | |
BG60043A3 (en) | Composition of dispersable granules and method for its preparation | |
TH15700A (th) | เม็ดที่ไม่มีการเคลือบ และวิธีการผลิตเม็ดดังกล่าว | |
GB2103215B (en) | Novel amidines, processes for their manufacture, pharmaceutical preparations containing them, and their use | |
TH50858A (th) | สารผสมเครื่องสำอางชนิดผงที่มีซิลิโคน อีลาสโตเมอร์ | |
TH11997EX (th) | ผงหล่อลื่นสำหรับการหล่ออัลลอยอะลูมิเนียม | |
JPS559032A (en) | Antiseptic and antifungal agent |